Logo
homeHome
toggle_offCompany ProfilegroupsBoards & Staffsworkspace_premiumMemberships & PartnersschoolAcademy of Journalismperson_addCareerslinkBlog(EN)emailContact Us
list_altOur JournalslightbulbInstruction for AuthorsbookmarkBrieflands PolicieshandshakePublish My Researchplay_circleJournal Management Systemcredit_cardArticle Processing Chargeszoom_inOpen Peer ReviewimagePublishing Services
menu_bookPublish My Book

Koomesh

Journal of Semnan University of Medical Sciences

homeHome
listAll Issuesplay_arrowIn Presscheck_circleAccepted ManuscriptssearchSearch
lightbulbInstructions
infoJournal InformationgroupsEditors & BoardspublicIndexing and Listing Sourcesquery_statsJournal Metricszoom_inOpen Peer Review (OPR)balancePublication Ethics and Publication Malpractice Statementassignment_indReviewer and AE Registration FormchatSupportphone_in_talkContact Us
euroAPC
Authors GuideSubmit Manuscript
koomesh

Image Credit:koomesh

Outlines

https://doi.org/10.69107/koomesh-153624

Assessment of the Antibacterial Activity of the Recombinant Protein Ib- AMP4 on Acinetobacter baumannii (ATCC19606) Under in vitro Conditions

Author(s):
Majid SafariMajid SafariMajid Safari ORCID1, Hamid AbtahiHamid AbtahiHamid Abtahi ORCID2,*, Shima ChehreiiShima ChehreiiShima Chehreii ORCID1, Shohreh FahimiradShohreh FahimiradShohreh Fahimirad ORCID2
1Department of Microbiology, Arak Branch, Islamic Azad University, Arak, Iran
2Molecular and Medicine Research Center, Arak University of Medical Sciences, Arak, Iran
Koomesh:Vol. 27, issue 5; e153624
Published online:Sep 21, 2025
Article type:Research Article
How to Cite:Safari M, Abtahi H, Chehreii S, Fahimirad S. Assessment of the Antibacterial Activity of the Recombinant Protein Ib- AMP4 on Acinetobacter baumannii (ATCC19606) Under in vitro Conditions. koomesh. 2025;27(5):e153624. doi: https://doi.org/10.69107/koomesh-153624

Abstract

Keywords
Antibacterial Peptides
Recombinant Proteins
Ib-AMP4 Peptide
Acinetobacter baumannii
Antimicrobial Peptides

References

  • 1.
    1. Chae YK, Kim SH, Markley JL. Relationship between recombinant protein expression and host metabolome as determined by two-dimensional NMR spectroscopy. PLoS One. 2017;12(5):e0177233. [PubMed ID:28486539]. [PubMed Central ID:PMC5423636]. https://doi.org/10.1371/journal.pone.0177233.
  • 2.
    2. Soltani M, Nassaji M, Ghorbani R. [Incidence, risk factors and prognosis of nosocomial pneumonia in adult patients admitted in the intensive care unit]. Koomesh. 2024;23(1):e153242. Persian.
  • 3.
    3. Yousefi B, Pakdel A, Hasanpour S, Abdolshahi A, Emadi A, Pahlevan D, et al. CTX-M gene and presence of insertion elements in patients with septicemia caused by Escherichia coli. Rev Res Med Microbiol. 2023;34(3):140-8. https://doi.org/10.1097/mrm.0000000000000337.
  • 4.
    4. Fishbain J, Peleg AY. Treatment of Acinetobacter infections. Clin Infect Dis. 2010;51(1):79-84. [PubMed ID:20504234]. https://doi.org/10.1086/653120.
  • 5.
    5. Yousefi M, Dadashpour M, Hejazi M, Hasanzadeh M, Behnam B, de la Guardia M, et al. Anti-bacterial activity of graphene oxide as a new weapon nanomaterial to combat multidrug-resistance bacteria. Mater Sci Eng C Mater Biol Appl. 2017;74:568-81. [PubMed ID:28254332]. https://doi.org/10.1016/j.msec.2016.12.125.
  • 6.
    6. Rezayi M, Mahmoodi P, Langari H, Behnam B, Sahebkar A. Conjugates of Curcumin with Graphene and Carbon Nanotubes: A Review on Biomedical Applications. Curr Med Chem. 2020;27(40):6849-63. [PubMed ID:31724497]. https://doi.org/10.2174/0929867326666191113145745.
  • 7.
    7. Butler DA, Biagi M, Tan X, Qasmieh S, Bulman ZP, Wenzler E. Multidrug Resistant Acinetobacter baumannii: Resistance by Any Other Name Would Still be Hard to Treat. Curr Infect Dis Rep. 2019;21(12):46. [PubMed ID:31734740]. https://doi.org/10.1007/s11908-019-0706-5.
  • 8.
    8. Maragakis Lisa L, Perl Trish M. Antimicrobial Resistance:Acinetobacter baumannii:Epidemiology, Antimicrobial Resistance, and Treatment Options. Clin Infect Dis. 2008;46(8):1254-63. https://doi.org/10.1086/529198.
  • 9.
    9. Ventola CL. The antibiotic resistance crisis: part 1: causes and threats. Pharm Therapeutics. 2015;40(4):277-83. [PubMed ID:25859123]. [PubMed Central ID:PMC4378521].
  • 10.
    10. Martin L, van Meegern A, Doemming S, Schuerholz T. Antimicrobial Peptides in Human Sepsis. Front Immunol. 2015;6:404. [PubMed ID:26347737]. [PubMed Central ID:PMC4542572]. https://doi.org/10.3389/fimmu.2015.00404.
  • 11.
    11. Nakatsuji T, Gallo RL. Antimicrobial peptides: old molecules with new ideas. J Invest Dermatol. 2012;132(3 Pt 2):887-95. [PubMed ID:22158560]. [PubMed Central ID:PMC3279605]. https://doi.org/10.1038/jid.2011.387.
  • 12.
    12. Fan X, Korytowski A, Makky A, Tanaka M, Wink M. Ib-AMP4 insertion causes surface rearrangement in the phospholipid bilayer of biomembranes: Implications from quartz-crystal microbalance with dissipation. Biochim Biophys Acta Biomembr. 2018;1860(2):617-23. [PubMed ID:29106975]. https://doi.org/10.1016/j.bbamem.2017.10.025.
  • 13.
    13. Cao H, Ke T, Liu R, Yu J, Dong C, Cheng M, et al. Identification of a Novel Proline-Rich Antimicrobial Peptide from Brassica napus. PLoS One. 2015;10(9):e0137414. [PubMed ID:26383098]. [PubMed Central ID:PMC4575134]. https://doi.org/10.1371/journal.pone.0137414.
  • 14.
    14. Michael CA, Dominey-Howes D, Labbate M. The antimicrobial resistance crisis: causes, consequences, and management. Front Public Health. 2014;2:145. [PubMed ID:25279369]. [PubMed Central ID:PMC4165128]. https://doi.org/10.3389/fpubh.2014.00145.
  • 15.
    15. Nguyen LT, Haney EF, Vogel HJ. The expanding scope of antimicrobial peptide structures and their modes of action. Trends Biotechnol. 2011;29(9):464-72. [PubMed ID:21680034]. https://doi.org/10.1016/j.tibtech.2011.05.001.
  • 16.
    16. Satei P, Ghaznavi-Rad E, Fahimirad S, Abtahi H. Recombinant production of Trx-Ib-AMP4 and Trx-E50-52 antimicrobial peptides and antimicrobial synergistic assessment on the treatment of methicillin-resistant Staphylococcus aureus under in vitro and in vivo situations. Protein Expr Purif. 2021;188:105949. [PubMed ID:34324967]. https://doi.org/10.1016/j.pep.2021.105949.
  • 17.
    17. Safari M, Rafiei Tabatabaei R, Abtahi H, Fahimirad S, Alimoradian A. In Vitro Pharmacokinetics of LL-37 and Oncorhyncin II Combination Against Acinetobacter baumannii. Jundishapur J Microbiol. 2023;15(11). https://doi.org/10.5812/jjm-131299.
  • 18.
    18. Rezaei L, Ayat HA, Ahadi AM. [Design and construction of pET32b(+)Rh expression vector based on pET system to facilitate purification]. Cell Mol Res (Iran J Biol). 2021;34(2):208-18. Persian.
  • 19.
    19. Molaee N, Abtahi H, Mosayebi G. Expression of recombinant streptokinase from streptococcus pyogenes and its reaction with infected human and murine sera. Iran J Basic Med Sci. 2013;16(9):985-9. [PubMed ID:24171077]. [PubMed Central ID:PMC3804847].
  • 20.
    20. Rai M, Padh H. Expression systems for production of heterologous proteins. Curr Sci. 2001;80(9):1121-8.
  • 21.
    21. Abtahi H, Salmanian AH, Rafati S, Behzadian Nejad G, Mohammad Hassan Z. High Level Expression of Recombinant Ribosomal Protein (L7/L12) from Brucella abortus and Its Reaction with Infected Human Sera. Iran Biomed J. 2004;8(1):13-8.
  • 22.
    22. Mirjamali NA-S, Soufian S, Molaee N, Sadoogh Abbasian S, Abtahi H. Cloning and expression of the enzymatic region of Streptococcal hyaluronidase. Iran J Basic Med Sci. 2014;17(9):667-72. https://doi.org/10.22038/ijbms.2014.3329.
  • 23.
    23. Howell MD, Jones JF, Kisich KO, Streib JE, Gallo RL, Leung DY. Selective killing of vaccinia virus by LL-37: implications for eczema vaccinatum. J Immunol. 2004;172(3):1763-7. [PubMed ID:14734759]. https://doi.org/10.4049/jimmunol.172.3.1763.
  • 24.
    24. Mahmoudi S, Abtahi H, Bahador A, Mosayebi G, Salmanian AH. Production of recombinant streptokinase in E. coli and reactivity with immunized mice. Pak J Biol Sci. 2010;13(8):380-4. [PubMed ID:20836298]. https://doi.org/10.3923/pjbs.2010.380.384.
  • 25.
    25. Jafari SF, Ghaznavi-Rad E, Fahimirad S, Abtahi H. Recombinant Oncorhyncin II Effect on the Treatment of Methicillin-Resistant Staphylococcus aureus Skin Infection. Jundishapur J Microbiol. 2020;13(4). https://doi.org/10.5812/jjm.95948.
  • 26.
    26. Sivashanmugam A, Murray V, Cui C, Zhang Y, Wang J, Li Q. Practical protocols for production of very high yields of recombinant proteins using Escherichia coli. Protein Sci. 2009;18(5):936-48. [PubMed ID:19384993]. [PubMed Central ID:PMC2771296]. https://doi.org/10.1002/pro.102.
  • 27.
    27. Robinette D, Wada S, Arroll T, Levy MG, Miller WL, Noga EJ. Antimicrobial activity in the skin of the channel catfish Ictalurus punctatus: characterization of broad-spectrum histone-like antimicrobial proteins. Cell Mol Life Sci. 1998;54(5):467-75. [PubMed ID:9645227]. [PubMed Central ID:PMC11147296]. https://doi.org/10.1007/s000180050175.
  • 28.
    28. Farjadi V, Abtahi H, Zolfaghari MR, Soufian S, Hasanzadeh L. Expression, Purification and Evaluation of Antigenicity of CagA Antigenic Fragment of Helicobacter pylori. Jundishapur J Microbiol. 2013;6(9). https://doi.org/10.5812/jjm.7367.
  • 29.
    29. Clinical and Laboratory Standards Institute. Methods for dilution antimicrobial susceptibility tests for bacteria that grow aerobically. Wayne, PA: Clinical and Laboratory Standards Institute; 2012. Available from: https://clsi.org/shop/standards/m07/.
  • 30.
    30. Abtahi H, Ghazavi A, Karimi M, Mollaghase S, Mosayebi G. Antimicrobial Activities of Water and Methanol Extracts of Bitter Apricot Seeds. J Med Sci. 2008;8(4):433-6. https://doi.org/10.3923/jms.2008.433.436.
  • 31.
    31. Dangel A, Ackermann N, Abdel-Hadi O, Maier R, Onder K, Francois P, et al. A de novo-designed antimicrobial peptide with activity against multiresistant Staphylococcus aureus acting on RsbW kinase. FASEB J. 2013;27(11):4476-88. [PubMed ID:23901070]. https://doi.org/10.1096/fj.13-234575.
  • 32.
    32. Elshikh M, Ahmed S, Funston S, Dunlop P, McGaw M, Marchant R, et al. Resazurin-based 96-well plate microdilution method for the determination of minimum inhibitory concentration of biosurfactants. Biotechnol Lett. 2016;38(6):1015-9. [PubMed ID:26969604]. [PubMed Central ID:PMC4853446]. https://doi.org/10.1007/s10529-016-2079-2.
  • 33.
    33. Fahimirad S, Razavi SH, Abtahi H, Alizadeh H, Ghorbanpour M. Recombinant Production and Antimicrobial Assessment of Beta Casein- IbAMP4 as a Novel Antimicrobial Polymeric Protein and its Synergistic Effects with Thymol. Int J Peptide Res Therapeutics. 2018;24(1):213-22. https://doi.org/10.1007/s10989-017-9605-5.
  • 34.
    34. Gopal R, Kim YG, Lee JH, Lee SK, Chae JD, Son BK, et al. Synergistic effects and antibiofilm properties of chimeric peptides against multidrug-resistant Acinetobacter baumannii strains. Antimicrob Agents Chemother. 2014;58(3):1622-9. [PubMed ID:24366740]. [PubMed Central ID:PMC3957903]. https://doi.org/10.1128/AAC.02473-13.
  • 35.
    35. Najar-Peerayeh S, Behmanesh M, Jazayeri Moghadas A. Staphylococcus epidermidis, Clonality and Accessory Gene Regulator Diversity in Clinical Isolates. Arch Clin Infect Dis. 2018;13(4). https://doi.org/10.5812/archcid.62833.
  • 36.
    36. Ghasemian A, Shokouhi Mostafavi SK, Marzi M, Rostami Chijan M, Kazemi M, Zarenezhad E. [The association of thioredoxin novel virulence factor in highly virulent Helicobacter pylori and gastric cancer and the anti-biofilm effects of natural bioactive compounds]. Med Sci J Islamic Azad Univ. 2023;33(3):205-18. Persian. https://doi.org/10.61186/iau.33.3.205.
  • 37.
    37. Dubos RJ. Studies on a Bactericidal Agent Extracted from a Soil Bacillus : I. Preparation of the Agent. Its Activity in Vitro. J Exp Med. 1939;70(1):1-10. [PubMed ID:19870884]. [PubMed Central ID:PMC2133784]. https://doi.org/10.1084/jem.70.1.1.
  • 38.
    38. Sadelaji S, Ghaznavi-Rad E, Sadoogh Abbasian S, Fahimirad S, Abtahi H. Ib-AMP4 antimicrobial peptide as a treatment for skin and systematic infection of methicillin-resistant Staphylococcus aureus (MRSA). Iran J Basic Med Sci. 2022;25(2):232-8. [PubMed ID:35655604]. [PubMed Central ID:PMC9124539]. https://doi.org/10.22038/IJBMS.2022.61043.13508.
  • 39.
    39. Liu L, Li H, Ma C, Liu J, Zhang Y, Xu D, et al. Effect of anti-biofilm peptide CRAMP-34 on the biofilms of Acinetobacter lwoffii derived from dairy cows. Front Cell Infect Microbiol. 2024;14:1406429. [PubMed ID:39211795]. [PubMed Central ID:PMC11358070]. https://doi.org/10.3389/fcimb.2024.1406429.
  • 40.
    40. Tavani ME, Poursaki T, Gharibi F. [The Necessity of Promoting Technology Commercialization in Iran’s Universities of Medical Sciences: A Policy Brief]. Koomesh. 2023;26(1). Persian.
Import into EndNoteImport into BibTex
Crossmark
Crossmark
Checking
Share on
Comments
Number of Comments:0
Cited by
Metrics
Licensing and reuse information

Ordering Reprints

Articles are published under the Creative Commons license stated on each article. No permission or royalty fee is required for uses permitted by that license. CCC handles optional bulk and customized reprint orders. Any quotation covers production and delivery services only, not copyright permission. > Request Reprints from CCC 

Search Relations

Author(s):

Related Articles

Related Article in PubMed

Related Article in Google Scholar

Create Citation Alert via Google Reader